149 related articles for article (PubMed ID: 17024289)
1. Boronated protohaemins: synthesis and in vivo antitumour efficacy.
Ol'shevskaya VA; Nikitina RG; Zaitsev AV; Luzgina VN; Kononova EG; Morozova TG; Drozhzhina VV; Ivanov OG; Kaplan MA; Kalinin VN; Shtil AA
Org Biomol Chem; 2006 Oct; 4(20):3815-21. PubMed ID: 17024289
[TBL] [Abstract][Full Text] [Related]
2. Novel boronated derivatives of 5,10,15,20-tetraphenylporphyrin: synthesis and toxicity for drug-resistant tumor cells.
Ol'shevskaya VA; Zaitsev AV; Luzgina VN; Kondratieva TT; Ivanov OG; Kononova EG; Petrovskii PV; Mironov AF; Kalinin VN; Hofmann J; Shtil AA
Bioorg Med Chem; 2006 Jan; 14(1):109-20. PubMed ID: 16185886
[TBL] [Abstract][Full Text] [Related]
3. Novel boronated chlorin e6-based photosensitizers: synthesis, binding to albumin and antitumour efficacy.
Ol'shevskaya VA; Nikitina RG; Savchenko AN; Malshakova MV; Vinogradov AM; Golovina GV; Belykh DV; Kutchin AV; Kaplan MA; Kalinin VN; Kuzmin VA; Shtil AA
Bioorg Med Chem; 2009 Feb; 17(3):1297-306. PubMed ID: 19121946
[TBL] [Abstract][Full Text] [Related]
4. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
Genady AR
Eur J Med Chem; 2009 Jan; 44(1):409-16. PubMed ID: 18407378
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy.
Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
J Med Chem; 2005 Feb; 48(4):1188-98. PubMed ID: 15715485
[TBL] [Abstract][Full Text] [Related]
6. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
7. Total syntheses of three copper (II) tetracarboranylphenylporphyrins containing 40 or 80 boron atoms and their biological properties in EMT-6 tumor-bearing mice.
Wu H; Micca PL; Makar MS; Miura M
Bioorg Med Chem; 2006 Aug; 14(15):5083-92. PubMed ID: 16651000
[TBL] [Abstract][Full Text] [Related]
8. A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies.
Jori G; Soncin M; Friso E; Vicente MG; Hao E; Miotto G; Colautti P; Moro D; Esposito J; Rosi G; Nava E; Sotti G; Fabris C
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S321-4. PubMed ID: 19376726
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological investigations of tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC).
Hao E; Friso E; Miotto G; Jori G; Soncin M; Fabris C; Sibrian-Vazquez M; Vicente MG
Org Biomol Chem; 2008 Oct; 6(20):3732-40. PubMed ID: 18843403
[TBL] [Abstract][Full Text] [Related]
10. Conjugates of boron clusters with derivatives of natural chlorin and bacteriochlorin.
Bregadze VI; Sivaev IB; Lobanova IA; Titeev RA; Brittal DI; Grin MA; Mironov AF
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S101-4. PubMed ID: 19447631
[TBL] [Abstract][Full Text] [Related]
11. Positive cooperativity in the cellular uptake of a boronated porphyrin.
Novick S; Laster B; Quastel MR
Int J Biochem Cell Biol; 2006; 38(8):1374-81. PubMed ID: 16616577
[TBL] [Abstract][Full Text] [Related]
12. Boron-containing protoporphyrin IX derivatives and their modification for boron neutron capture therapy: synthesis, characterization, and comparative in vitro toxicity evaluation.
El-Zaria ME; Ban HS; Nakamura H
Chemistry; 2010 Feb; 16(5):1543-52. PubMed ID: 20020518
[TBL] [Abstract][Full Text] [Related]
13. In vitro neutron irradiation of glioma and endothelial cultured cells.
Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
[TBL] [Abstract][Full Text] [Related]
14. New potential anticancer agent of carborane derivatives: selective cellular interaction and activity of ferrocene-substituted dithio-o-carborane conjugates.
Wu C; Ye H; Bai W; Li Q; Guo D; Lv G; Yan H; Wang X
Bioconjug Chem; 2011 Jan; 22(1):16-25. PubMed ID: 21162536
[TBL] [Abstract][Full Text] [Related]
15. Intracellular uptake of a new boronated porphyrin EC032.
Tsurubuchi T; Yamamoto T; Nakai K; Zaboronok A; Yoshida F; Miyakawa M; Shirakawa M; Yamamoto Y; Matsuda M; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S94-6. PubMed ID: 19410469
[TBL] [Abstract][Full Text] [Related]
16. Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors.
Byun Y; Thirumamagal BT; Yang W; Eriksson S; Barth RF; Tjarks W
J Med Chem; 2006 Sep; 49(18):5513-23. PubMed ID: 16942024
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of new pentaphyrin macrocycles for photodynamic therapy.
Comuzzi C; Cogoi S; Overhand M; Van der Marel GA; Overkleeft HS; Xodo LE
J Med Chem; 2006 Jan; 49(1):196-204. PubMed ID: 16392804
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy.
Renner MW; Miura M; Easson MW; Vicente MG
Anticancer Agents Med Chem; 2006 Mar; 6(2):145-57. PubMed ID: 16529537
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of carboranes containing an azulene framework and in vitro evaluation as boron carriers.
Nakamura H; Sekido M; Yamamoto Y
J Med Chem; 1997 Aug; 40(18):2825-30. PubMed ID: 9288164
[TBL] [Abstract][Full Text] [Related]
20. Bacteriochlorophyll a, and its derivatives: chemistry and perspectives for cancer therapy.
Grin MC; Capital Em Cyrillicironov CA; Shtil AC
Anticancer Agents Med Chem; 2008 Aug; 8(6):683-97. PubMed ID: 18690829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
